361 related articles for article (PubMed ID: 19789062)
1. Overweight and obesity: the pathogenesis of cardiometabolic risk.
Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Goralski KB; Sinal CJ
Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
[TBL] [Abstract][Full Text] [Related]
3. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
Haffner SM
Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
[TBL] [Abstract][Full Text] [Related]
4. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
López-Jaramillo P; Gómez-Arbeláez D; López-López J; López-López C; Martínez-Ortega J; Gómez-Rodríguez A; Triana-Cubillos S
Horm Mol Biol Clin Investig; 2014 Apr; 18(1):37-45. PubMed ID: 25389999
[TBL] [Abstract][Full Text] [Related]
5. The link between abdominal obesity and the metabolic syndrome.
Phillips LK; Prins JB
Curr Hypertens Rep; 2008 Apr; 10(2):156-64. PubMed ID: 18474184
[TBL] [Abstract][Full Text] [Related]
6. Obesity, abdominal obesity, and insulin resistance.
Westphal SA
Clin Cornerstone; 2008; 9(1):23-29; discussion 30-1. PubMed ID: 19046737
[TBL] [Abstract][Full Text] [Related]
7. Guiding clinical decisions on abdominal obesity and cardiometabolic risk.
Nesto RW; Nelinson DS; Pagotto U
Clin Cornerstone; 2009; 9(4):43-52; discussion 53-4. PubMed ID: 19789063
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
[TBL] [Abstract][Full Text] [Related]
9. The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.
Barnett AH
Diab Vasc Dis Res; 2008 Mar; 5(1):9-14. PubMed ID: 18398806
[TBL] [Abstract][Full Text] [Related]
10. [Abdominal obesity and diabetes].
Bonora E; Brangani C; Pichiri I
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):40S-53S. PubMed ID: 18773750
[TBL] [Abstract][Full Text] [Related]
11. Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
Supriya R; Tam BT; Yu AP; Lee PH; Lai CW; Cheng KK; Yau SY; Chan LW; Yung BY; Sheridan S; Siu PM
PLoS One; 2018; 13(8):e0201585. PubMed ID: 30114249
[TBL] [Abstract][Full Text] [Related]
12. Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.
Wittwer J; Bradley D
Front Immunol; 2021; 12():612496. PubMed ID: 33717095
[TBL] [Abstract][Full Text] [Related]
13. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.
Boulet MM; Chevrier G; Grenier-Larouche T; Pelletier M; Nadeau M; Scarpa J; Prehn C; Marette A; Adamski J; Tchernof A
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E736-46. PubMed ID: 26306599
[TBL] [Abstract][Full Text] [Related]
14. The mechanisms linking adiposopathy to type 2 diabetes.
Yang J; Kang J; Guan Y
Front Med; 2013 Dec; 7(4):433-44. PubMed ID: 24085616
[TBL] [Abstract][Full Text] [Related]
15. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
Pahwa R; Adams-Huet B; Jialal I
J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid system and cardiometabolic risk.
Saavedra LE
Clin Pharmacol Ther; 2007 Nov; 82(5):591-4. PubMed ID: 17898706
[TBL] [Abstract][Full Text] [Related]
17. Should adipokines be considered in the choice of the treatment of obesity-related health problems?
Athyros VG; Tziomalos K; Karagiannis A; Anagnostis P; Mikhailidis DP
Curr Drug Targets; 2010 Jan; 11(1):122-35. PubMed ID: 20017725
[TBL] [Abstract][Full Text] [Related]
18. Obesity and metabolic syndrome as related to cardiovascular disease.
Nikolopoulou A; Kadoglou NP
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
[TBL] [Abstract][Full Text] [Related]
19. Adipokines and hepatic insulin resistance.
Li Y; Ding L; Hassan W; Abdelkader D; Shang J
J Diabetes Res; 2013; 2013():170532. PubMed ID: 23762871
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality.
Lee CH; Lui DTW; Lam KSL
Front Immunol; 2021; 12():589206. PubMed ID: 33815359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
